Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications

被引：0
|
作者：
Velentgas, P
West, W
Cannuscio, CC
Watson, DJ
Walker, AM
机构：
[1] Ingenix, Auburndale, MA USA
[2] Merck Res Labs, Blue Bell, PA USA
来源：
CIRCULATION | 2005年 / 111卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P204
引用
收藏
页码：E226 / E226
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. (vol 15, pg 360, 2006)
    Velentgas, P
    West, W
    Cannuscio, CC
    Watson, DJ
    Walker, AM
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (05) : 360 - 360
  • [2] Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspinn non-steroidal anti-inflammatory medications
    Velentgas, Priscilla
    West, William
    Cannuscio, Carolyn C.
    Watson, Douglas J.
    Walker, Alexander M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (09) : 641 - 652
  • [3] The administration of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors in dentistry
    Vardar, S
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) : 1735 - 1736
  • [4] Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors
    Cheng, HF
    Harris, RC
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) : 1795 - 1804
  • [5] The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin
    Kimmel, SE
    Berlin, JA
    Reilly, M
    Jaskowiak, J
    Kishel, L
    Chittams, J
    Strom, BL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) : 985 - 990
  • [6] Cardiovascular risks associated with non-aspirin non-steroidal anti-inflammatory drug use
    Schmidt, Morten
    DANISH MEDICAL JOURNAL, 2015, 62 (03):
  • [7] Non-steroidal anti-inflammatory drugs and the risk of cardiovascular diseases Are we going to see the revival of cyclooxygenase-2 selective inhibitors?
    Gluszko, Piotr
    Bielinska, Aneta
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (04): : 231 - 234
  • [8] Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer
    Lim, Wei-Yen
    Chuah, Khoon Leong
    Eng, Philip
    Leong, Swan Swan
    Lim, Elaine
    Lim, Tow Keang
    Ng, Alan
    Poh, Wee Teng
    Tee, Augustine
    Teh, Ming
    Salim, Agus
    Seow, Adeline
    LUNG CANCER, 2012, 77 (02) : 246 - 251
  • [9] Increased mortality and cardiovascular risk associated with non-selective non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors in chronic heart failure
    Gislason, G. H.
    Rasmussen, J. N.
    Abildstrom, S. Z.
    Schramm, T. K.
    Hansen, M. L.
    Folke, F.
    Rasmussen, S.
    Kober, L.
    Madsen, M.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2007, 28 : 45 - 45
  • [10] The risk of congestive heart failure with non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors - A class effect?
    Hudson, M
    Rahme, E
    Richard, H
    Pilote, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S402 - S402
12345